药理上增强多巴胺神经传递不会影响幻觉模式感知
Elke Smith1, Simon Michalski2, Kilian Knauth2
1Department of Psychology, Biological Psychology, University of Cologne, Cologne 50969, Germany e.smith@uni-koeln.de.
eNeuro
|July 12, 2024
概括
这项研究没有发现L-DOPA影响健康个体虚幻模式知觉的证据. 与预测相反,多巴胺操纵并没有增加在噪音中看到模式的可能性.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
背景情况:
- 多巴胺传播与精神病症状和妄想信念有关.
- 噪音中的虚幻模式感知是提出的一种机制,但多巴胺的作用尚不清楚.
研究的目的:
- 研究操纵多巴胺基神经传递对健康成年人虚幻模式知觉的影响.
- 为了确定L-DOPA是否会影响噪音模式的检测.
主要方法:
- 双盲,安慰剂控制的,在48名健康参与者的实验对象内设计.
- 使用信号检测模型评估虚幻模式感知.
- 使用L-DOPA操纵多巴胺基神经传递.
主要成果:
- 与安慰剂相比,没有可信的证据表明L-DOPA增加了虚假警报率.
- L-DOPA没有可靠地改变准确性,歧视敏感性或响应偏差.
- 贝叶斯统计数据支持了零假设,表明没有显著的影响.
结论:
- 该研究发现L-DOPA对健康个体的虚幻模式知觉没有显著影响.
- 结果表明多巴胺可能不会在健康人群中在这个特定的认知过程中发挥关键作用.
- 建议在未来研究更大的样本大小和多样化的设计.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
CNS Stimulants: Psychedelic Agents
141
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
141
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
118
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
118


